| __timestamp | Insmed Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 33534999 | 205018000 |
| Thursday, January 1, 2015 | 1982000 | 392709000 |
| Friday, January 1, 2016 | 2438000 | 299694000 |
| Sunday, January 1, 2017 | 2901000 | 397061000 |
| Monday, January 1, 2018 | 2423000 | 434100000 |
| Tuesday, January 1, 2019 | 24212000 | 782200000 |
| Wednesday, January 1, 2020 | 39872000 | 1119900000 |
| Friday, January 1, 2021 | 44152000 | 2437500000 |
| Saturday, January 1, 2022 | 55126000 | 1560400000 |
| Sunday, January 1, 2023 | 65573000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
In pursuit of knowledge
In the competitive landscape of biopharmaceuticals, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Regeneron Pharmaceuticals, Inc. and Insmed Incorporated from 2014 to 2023. Over this period, Regeneron consistently outpaced Insmed, with its cost of revenue peaking at approximately $2.44 billion in 2021, a staggering 370% increase from 2014. In contrast, Insmed's cost of revenue grew by about 95% over the same period, reaching around $65.6 million in 2023.
This data underscores the dynamic nature of the biopharmaceutical industry, where strategic cost management can significantly impact a company's competitive edge.
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Insmed Incorporated
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Insmed Incorporated's Expenses
Cost of Revenue Comparison: Insmed Incorporated vs Walgreens Boots Alliance, Inc.
Insmed Incorporated vs Exelixis, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited